SCHEMBL580048

SCHEMBL580048

CN=C(N)NCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL4743453 0.98 CTH (0.41)
Hydrochloric Acid SCHEMBL11809897 0.98 CTH (0.41)
Hydrochloric Acid SCHEMBL11809895 0.98 CTH (0.41)
SCHEMBL22492467 0.85
SCHEMBL5675791 0.83
SCHEMBL12292242 0.81
SCHEMBL24021305 0.78
SCHEMBL21461380 0.78
SCHEMBL18541270 0.78
SCHEMBL7859372 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024253632-A1 COMPOSITE EUGEROIC Козловский, Вадим Алексеевич 2024-12-12 WO claimed
EP-2704596-B1 ORAL COMPOSITIONS COMPRISING CREATINE PATENTNAV IRELAND LTD (IE) 2018-10-17 EP claimed
US-20160160447-A1 Guanidyl Paper Coating Polymer Ventures Inc. (US) 2016-06-09 US claimed
US-8631868-B1 Treatment of subterranean formations Polymer Ventures Inc. (US) 2014-01-21 US claimed
US-8220565-B1 Treatment of subterranean formations POLYMER VENTURES, INC. (US) 2012-07-17 US claimed
US-20120160485-A1 Treatment of Subterranean Formations POLYMER VENTURES, INC. (US) 2012-06-28 US claimed
EP-4522144-B1 COMPOSITION COMPRISING CREATINE FOR USE IN THE TREATMENT OF BREATHING DIFFICULTIES ALZCHEM TROSTBERG GMBH (DE) 2026-03-11 EP disclosed
US-20250325505-A1 COMPOSITION COMPRISING CREATINE FOR USE IN THE TREATMENT OF BREATHING DIFFICULTIES ALZCHEM TROSTBERG GMBH (DE) 2025-10-23 US disclosed
US-20250302788-A1 COMPOSITION COMPRISING CREATINE FOR USE IN THE TREATMENT OF POST VIRAL FATIGUE SYNDROME ALZCHEM TROSTBERG GMBH (DE) 2025-10-02 US disclosed
EP-4522145-A1 COMPOSITION COMPRISING CREATINE FOR USE IN THE TREATMENT OF POST VIRAL FATIGUE SYNDROME AlzChem Trostberg GmbH (DE) 2025-03-19 EP disclosed
EP-4522144-A1 COMPOSITION COMPRISING CREATINE FOR USE IN THE TREATMENT OF BREATHING DIFFICULTIES Alzchem Trostberg GmbH (DE) 2025-03-19 EP disclosed
WO-2024253632-A1 COMPOSITE EUGEROIC Козловский, Вадим Алексеевич 2024-12-12 WO disclosed
CN-119039182-A Preparation method for continuously producing high-purity creatine monohydrate 河北博泽化工有限责任公司 2024-11-29 CN disclosed
US-20120121485-A1 PROCESS FOR REMOVING METALS FROM HYDROCARBONS PETROLIAM NASIONAL BERHAD (PETRONAS) (MY) 2012-05-17 US disclosed
EP-2417225-A2 PROCESS FOR REMOVING METALS FROM HYDROCARBONS Petroliam Nasional Berhad (PETRONAS) (MY) 2012-02-15 EP disclosed
WO-2010116165-A2 PROCESS FOR REMOVING METALS FROM HYDROCARBONS PETROLIAM NASIONAL BERHAD (PETRONAS) (MY) 2010-10-14 WO disclosed
WO-2008031184-A1 CREATINE PYROGLUTAMIC ACID SALTS AND METHODS FOR THEIR PRODUCTION AND USE IN INDIVIDUALS NEW CELL FORMULATIONS LTD. (CA) 2008-03-20 WO disclosed
US-6008252-A Method for increasing muscle mass in a mammal BEALE PAXTON K (US) 1999-12-28 US disclosed
US-3972872-A BACTERICIDE, ANIMAL FEED SUPPLEMENT PFIZER INC. (US) 1976-08-03 US disclosed
US-3933797-A 6-[α-(ω-QUANIDINOALKANOYLAMIDO)ACYLAMIDO]PENICILLANIC ACIDS PFIZER INC. (US) 1976-01-20 US disclosed